241 – 250 of 473
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Extent of myocardium at risk for left anterior descending artery, right coronary artery, and left circumflex artery occlusion depicted by contrast-enhanced steady state free precession and T2-weighted short tau inversion recovery magnetic resonance imaging
(
- Contribution to journal › Article
-
Mark
Multi-vendor, multicentre comparison of contrast-enhanced SSFP and T2-STIR CMR for determining myocardium at risk in ST-elevation myocardial infarction
(
- Contribution to journal › Article
-
Mark
The SOCCER-study: Effects of Oxygen Therapy on Myocardial Salvage in ST Elevation Myocardial Infarction – A Randomized Trial
2016) The National Meeting in Emergency Medicine, 2016(
- Contribution to conference › Poster
-
Mark
Relationship of Platelet Reactivity With Bleeding Outcomes During Long-Term Treatment With Dual Antiplatelet Therapy For Medically Managed Patients With Non-St-Segment Elevation Acute Coronary Syndromes
(
- Contribution to journal › Article
-
Mark
Association of circulating MicroRNA-124-3p levels with outcomes after out-of-hospital cardiac arrest : A substudy of a randomized clinical trial
(
- Contribution to journal › Article
-
Mark
Elevated CA125 is associated with incident heart failure and increased mortality in patients with acute coronary syndrome
(
- Contribution to journal › Published meeting abstract
-
Mark
Diagnosis and management of non-STEMI coronary syndromes
2016) p.678-681(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Diagnosis and management of ST-elevation of myocardial infarction
2016) p.682-687(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Impact on long-term mortality of presence of obstructive coronary artery disease and classification of myocardial infarction.
(
- Contribution to journal › Article
-
Mark
Sample Size in Clinical Cardioprotection Trials Using Myocardial Salvage Index, Infarct Size, or Biochemical Markers as Endpoint.
(
- Contribution to journal › Article